Organon & Co. (OGN)
13.34
+0.02
(+0.15%)
USD |
NYSE |
Apr 29, 16:00
13.32
-0.02
(-0.15%)
After-Hours: 20:00
Price Chart
Key Stats
| Price and Performance | |
|---|---|
| Market Cap | 3.473B |
| 52 Week High (Daily) | |
| 52 Week Low (Daily) | |
| All-Time High (Daily) | |
| Year to Date Total Returns (Daily) | |
| 1 Month Total Returns (Daily) | |
| 1 Year Total Returns (Daily) | 2.36% |
| Valuation | |
| PE Ratio | 18.62 |
| PE Ratio (Forward) | |
| PS Ratio | 0.559 |
| Price to Book Value | 4.618 |
| EV to EBITDA | |
| Dividend | |
|---|---|
| Dividend | 0.02 |
| Dividend Yield (Forward) | |
| Financials | |
| Revenue (5 Year Growth) | |
| Revenue (Quarterly YoY Growth) | |
| EPS Diluted (5 Year Growth) | |
| EPS Diluted (Quarterly YoY Growth) | |
| Debt to Equity Ratio | 11.70 |
| Return on Equity | |
| Return on Assets | |
| Risk | |
| Beta (5Y) | |
| Max Drawdown (5Y) | -- |
Profile
| Organon & Co. is a science based global pharmaceutical company, which develops and delivers innovative health solutions through a portfolio of prescription therapies within women’s health, biosimilars and established brands. The company was founded on March 11, 2020, and is headquartered in Jersey City, NJ. |
| URL | http://www.organon.com |
| Investor Relations URL | N/A |
| HQ State/Province | New Jersey |
| Sector | Health Care |
| Industry | Pharmaceuticals |
| Next Earnings Release | Apr. 30, 2026 |
| Last Earnings Release | Apr. 30, 2026 |
| Next Ex-Dividend Date | N/A |
| Last Ex-Dividend Date | Feb. 23, 2026 |
Profile
| Organon & Co. is a science based global pharmaceutical company, which develops and delivers innovative health solutions through a portfolio of prescription therapies within women’s health, biosimilars and established brands. The company was founded on March 11, 2020, and is headquartered in Jersey City, NJ. |
| URL | http://www.organon.com |
| Investor Relations URL | N/A |
| HQ State/Province | New Jersey |
| Sector | Health Care |
| Industry | Pharmaceuticals |
| Next Earnings Release | Apr. 30, 2026 |
| Last Earnings Release | Apr. 30, 2026 |
| Next Ex-Dividend Date | N/A |
| Last Ex-Dividend Date | Feb. 23, 2026 |